Random Posts
- Diabetes Diet Menu - Nutritional Management of Diabetes
- How to Change Your Diet If You Are a Type 2 Diabetic - Get Started Today
- Diabetic Cooking - The Importance of Diet
- Your Guide to Diabetes - Type 1 and Type 2 Explained
- Beta Cells and Diabetes - Regeneration of Beta Cells With Herbs
- Insulin Resistance and Diabetes
- Diabetes is Directly Related to Your Weight
- Why I Chose an Insulin Pump to Help Manage My Diabetes
Prescription Diabetes Drugs
Posted by admin in Prescription Diabetes Drugs on August 20th, 2010
Sensor-augmented insulin pump therapy achieves significantly better glycemic control in patients with Type 1 diabetes than multiple insulin injections, show results from the STAR 3 study.
The Sensor-Augmented Pump Therapy for A1C Reduction (STAR) 3 study was set up to evaluate the use of a continuous glucose monitor combined with a glucose pump, compared with standard injection therapy in 485 Type 1 diabetics (329 adults, 156 children) with poor glycemic control over a period of 1 year.
Richard Bergenstal (International Diabetes Center at Park Nicollet, Minneapolis, Minnesota, USA) and team report that at study completion, mean glycated hemoglobin (HbA1c) - 8.3% in both groups at baseline - had decreased significantly to 7.5% in the insulin pump group versus 8.1% in the multiple injections group.
In addition, 27% of patients in the insulin pump group achieved their target HbA1c of below 7% compared with only 10% of the multiple injection group.
Rates of severe hypoglycemia were similar in both groups at 13.31 and 13.48 cases per 100 person-years, respectively, in the insulin pump and multiple injection groups. No significant weight gain was observed in either group.
In an accompanying editorial, Howard Wolpert (Joslin Diabetes Center, Boston, Massachusetts, USA) commented: “The STAR 3 study and other randomized trials have shown that continuous glucose monitoring can take the management of Type 1 diabetes to a new level: improved glycemic control without an associated increase in hypoglycemia.”
He said: “The focus now has to move on to translating this evidence into effective practice so that the broader population of patients with Type 1 diabetes can realize these benefits.”
The results of this study are published in the New England Journal of Medicine.
MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010
- Natural Ways to Stop Diabetes
- Take Charge of Your Health - Preventing Diabetes
- Diabetes and Exercise - What is the Connection?
- Important Information For Diabetics
- You Can Now Get a 100% Free Diabetic Diet Plan Online If You Are Suffering With Symptoms
- Some Fruits For Diabetics
- Finding a Personally-Designed Weight Loss Diabetes Diet
- How to Keep Insulin Your Friend and Not Your Foe
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.